American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

Published on June 19, 2020 by

← Go back

Ow Laboratory

Investigator NameThomas Ow

Investigator InstitutionMontefiore Medical Center/Albert Einstein College of Medicine

Investigator TitleAssociate Professor

Investigator EmailEmail hidden; Javascript is required.

Investigator Phone(718) 920-8488

Laboratory Contact NameThomas Ow
Laboratory Contact TitlePI
Email hidden; Javascript is required.
Phone(718) 920-8488
Laboratory Areas of Expertise
  • Genomics
  • Tumor biology
  • Molecular & cell biology
  • Other
Lab Description

Dr. Ow is a Head and Neck Surgeon and Translational Researcher at Montefiore Medical Center-Albert Einstein College of Medicine.

Dr. Ow’s research is focused on the translation of genetic and molecular determinants in head and neck squamous cell cancer into clinically useful biomarkers and therapeutic targets.  Specifically, Dr. Ow is studying factors that contribute to radiation and chemotherapy resistance in this disease, as well as genomic alterations acquired during the process of locoregional recurrence, lymph node spread, and distant metastasis.  As a translational scientist, Dr. Ow is involved in active projects studying  laboratory models of HNSCC, research utilizing patient's tumors, as well as clinical research - both retrospective studies and prospective clinical trials.  The ultimate goal of this work is to identify novel ways to improve the survival and functional outcomes among patients with HNSCC.

We have a robust head and neck squamous cell carcinoma tissue bank, which includes stored nucleotides (DNA, RNA) from tumor and matched normal, as well as banked pre- and post- treatment blood samples for a subset of patients.  We have also used a technique called "conditional reprogramming" to establish cell line models from patients treated at our institution.  These resources are linked to a detailed clinical database, which stores key information in a de-identified fashion.

Omics Datasets
Description of Dataset Type of Dataset
We have microarray data (Illumina platform - gene expression, methylation, microRNA) obtained from tumor and matched normal from patients with head and neck sqamous cell carcinoma. There are >100 patients represented in each dataset, many of whom are overlapping, represented on all 3 platforms. gene expression microarray, methylation array, microRNA array

Entry DateOctober 7, 2021
Date UpdatedOctober 7, 2021

Related

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc